Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Initial outcomes of a real-world multi-site primary care psychotherapy program.

Sawchuk CN, Craner JR, Berg SL, Smyth K, Mack J, Glader M, Burke L, Haggerty S, Johnson M, Miller S, Sedivy S, Morcomb D, Heredia D, Williams MW, Katzelnick DJ.

Gen Hosp Psychiatry. 2018 Sep - Oct;54:5-11. doi: 10.1016/j.genhosppsych.2018.06.005. Epub 2018 Jun 24.

PMID:
30029160
2.

An Update on Telepsychiatry and How It Can Leverage Collaborative, Stepped, and Integrated Services to Primary Care.

Hilty DM, Rabinowitz T, McCarron RM, Katzelnick DJ, Chang T, Bauer AM, Fortney J.

Psychosomatics. 2018 May - Jun;59(3):227-250. doi: 10.1016/j.psym.2017.12.005. Epub 2017 Dec 26. Review.

PMID:
29544663
3.

A quality improvement project aimed at adapting primary care to ensure the delivery of evidence-based psychotherapy for adult anxiety.

Williams MD, Sawchuk CN, Shippee ND, Somers KJ, Berg SL, Mitchell JD, Mattson AB, Katzelnick DJ.

BMJ Open Qual. 2018 Jan 9;7(1):e000066. doi: 10.1136/bmjoq-2017-000066. eCollection 2018.

4.

Patient-Centered Medical Home Membership Is Associated with Decreased Hospital Admissions for Emergency Department Behavioral Health Patients.

Adaji A, Melin GJ, Campbell RL, Lohse CM, Westphal JJ, Katzelnick DJ.

Popul Health Manag. 2018 Jun;21(3):172-179. doi: 10.1089/pop.2016.0189. Epub 2017 May 9.

PMID:
28486061
5.

Prediction of Primary Care Depression Outcomes at Six Months: Validation of DOC-6 ©.

Angstman KB, Garrison GM, Gonzalez CA, Cozine DW, Cozine EW, Katzelnick DJ.

J Am Board Fam Med. 2017 May-Jun;30(3):281-287. doi: 10.3122/jabfm.2017.03.160313.

6.

Large-Scale Dissemination of Collaborative Care and Implications for Psychiatry.

Katzelnick DJ, Williams MD.

Psychiatr Serv. 2015 Sep;66(9):904-6. doi: 10.1176/appi.ps.201400529. Epub 2015 Jun 1. Review.

PMID:
26030320
7.

Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.

Mrazek DA, Biernacka JM, McAlpine DE, Benitez J, Karpyak VM, Williams MD, Hall-Flavin DK, Netzel PJ, Passov V, Rohland BM, Shinozaki G, Hoberg AA, Snyder KA, Drews MS, Skime MK, Sagen JA, Schaid DJ, Weinshilboum R, Katzelnick DJ.

J Clin Psychopharmacol. 2014 Jun;34(3):313-7. doi: 10.1097/JCP.0000000000000099. Erratum in: J Clin Psychopharmacol. 2014 Oct;34(5):558.

8.

Impact of symptom remission on outpatient visits in depressed primary care patients treated with collaborative care management and usual care.

Meunier MR, Angstman KB, MacLaughlin KL, Oberhelman SS, Rohrer JE, Katzelnick DJ, Matthews MR.

Popul Health Manag. 2014 Jun;17(3):180-4. doi: 10.1089/pop.2013.0057. Epub 2014 Feb 4.

PMID:
24495212
9.

Integration of mental health resources in a primary care setting leads to increased provider satisfaction and patient access.

Vickers KS, Ridgeway JL, Hathaway JC, Egginton JS, Kaderlik AB, Katzelnick DJ.

Gen Hosp Psychiatry. 2013 Sep-Oct;35(5):461-7. doi: 10.1016/j.genhosppsych.2013.06.011. Epub 2013 Jul 30.

PMID:
23910217
10.

Sustaining practice change one year after completion of the national depression management leadership initiative.

Chung H, Duffy FF, Katzelnick DJ, Williams MD, Trivedi MH, Rae DS, Regier DA.

Psychiatr Serv. 2013 Jul 1;64(7):703-6. doi: 10.1176/appi.ps.201200227.

PMID:
23821170
11.

Depression remission after six months of collaborative care management: role of initial severity of depression in outcome.

Angstman KB, Pietruszewski P, Rasmussen NH, Wilkinson JM, Katzelnick DJ.

Ment Health Fam Med. 2012 Jun;9(2):99-106.

12.

Patient self-assessment factors predictive of persistent depressive symptoms 6 months after enrollment in collaborative care management.

Angstman KB, Shippee ND, Maclaughlin KL, Rasmussen NH, Wilkinson JM, Williams MD, Katzelnick DJ.

Depress Anxiety. 2013 Feb;30(2):143-8. doi: 10.1002/da.22020. Epub 2012 Nov 8.

PMID:
23139162
13.

Age of depressed patient does not affect clinical outcome in collaborative care management.

Angstman KB, MacLaughlin KL, Rasmussen NH, DeJesus RS, Katzelnick DJ.

Postgrad Med. 2011 Sep;123(5):122-8. doi: 10.3810/pgm.2011.09.2467.

PMID:
21904094
14.

Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity.

Katzelnick DJ, Duffy FF, Chung H, Regier DA, Rae DS, Trivedi MH.

Psychiatr Serv. 2011 Aug;62(8):929-35. doi: 10.1176/ps.62.8.pss6208_0929.

PMID:
21807833
15.

Feasibility and validation of a computer-automated Columbia-Suicide Severity Rating Scale using interactive voice response technology.

Mundt JC, Greist JH, Gelenberg AJ, Katzelnick DJ, Jefferson JW, Modell JG.

J Psychiatr Res. 2010 Dec;44(16):1224-8. doi: 10.1016/j.jpsychires.2010.04.025. Epub 2010 Jun 2.

PMID:
20553851
16.

Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry?

Duffy FF, Chung H, Trivedi M, Rae DS, Regier DA, Katzelnick DJ.

Psychiatr Serv. 2008 Oct;59(10):1148-54. doi: 10.1176/appi.ps.59.10.1148.

PMID:
18832500
17.

Is it easier to find what you are looking for if you think you know what it looks like?

Mundt JC, Greist JH, Jefferson JW, Katzelnick DJ, DeBrota DJ, Chappell PB, Modell JG.

J Clin Psychopharmacol. 2007 Apr;27(2):121-5. No abstract available.

PMID:
17414233
20.
21.

Applying depression-specific change concepts in a collaborative breakthrough series.

Katzelnick DJ, Von Korff M, Chung H, Provost LP, Wagner EH.

Jt Comm J Qual Patient Saf. 2005 Jul;31(7):386-97.

PMID:
16130982
22.

Validation of an IVRS version of the MADRS.

Mundt JC, Katzelnick DJ, Kennedy SH, Eisfeld BS, Bouffard BB, Greist JH.

J Psychiatr Res. 2006 Apr;40(3):243-6. Epub 2005 Jun 24.

PMID:
15979643
23.

Prevalence and burden of illness of migraine in managed care patients.

Kobak KA, Katzelnick DJ, Sands G, King M, Greist JJ, Dominski M.

J Manag Care Pharm. 2005 Mar;11(2):124-36.

24.

Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence.

Kobak KA, Taylor Lv, Katzelnick DJ, Olson N, Clagnaz P, Henk HJ.

J Clin Psychiatry. 2002 Aug;63(8):727-32.

PMID:
12197454
25.

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ.

J Clin Psychopharmacol. 2002 Jun;22(3):257-62.

PMID:
12006895
26.

Impact of generalized social anxiety disorder in managed care.

Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP.

Am J Psychiatry. 2001 Dec;158(12):1999-2007.

PMID:
11729016
27.

Does physician education on depression management improve treatment in primary care?

Lin EH, Simon GE, Katzelnick DJ, Pearson SD.

J Gen Intern Med. 2001 Sep;16(9):614-9.

28.

New technologies to improve clinical trials.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Mundt JC.

J Clin Psychopharmacol. 2001 Jun;21(3):255-6. No abstract available.

PMID:
11386486
29.

Social anxiety disorder: an unrecognized problem in primary care.

Katzelnick DJ, Greist JH.

J Clin Psychiatry. 2001;62 Suppl 1:11-5; discussion 15-6. Review.

30.

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care.

Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS.

Arch Gen Psychiatry. 2001 Feb;58(2):181-7.

PMID:
11177120
31.

Randomized trial of a depression management program in high utilizers of medical care.

Katzelnick DJ, Simon GE, Pearson SD, Manning WG, Helstad CP, Henk HJ, Cole SM, Lin EH, Taylor LH, Kobak KA.

Arch Fam Med. 2000 Apr;9(4):345-51.

PMID:
10776363
32.

Depression among high utilizers of medical care.

Pearson SD, Katzelnick DJ, Simon GE, Manning WG, Helstad CP, Henk HJ.

J Gen Intern Med. 1999 Aug;14(8):461-8.

33.

Treatment of social phobia with gabapentin: a placebo-controlled study.

Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM.

J Clin Psychopharmacol. 1999 Aug;19(4):341-8.

PMID:
10440462
34.

Computerized assessment of depression and anxiety over the telephone using interactive voice response.

Kobak KA, Greist JH, Jefferson JW, Mundt JC, Katzelnick DJ.

MD Comput. 1999 May-Jun;16(3):64-8.

PMID:
10439605
35.

Computer-administered rating scales for social anxiety in a clinical drug trial.

Kobak KA, Schaettle SC, Greist JH, Jefferson JW, Katzelnick DJ, Dottl SL.

Depress Anxiety. 1998;7(3):97-104.

PMID:
9656089
36.

Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ, Henk HJ.

Psychopharmacology (Berl). 1998 Apr;136(3):205-16.

PMID:
9566805
37.

Administration of the Hamilton Depression Rating Scale using interactive voice response technology.

Mundt JC, Kobak KA, Taylor LV, Mantle JM, Jefferson JW, Katzelnick DJ, Greist JH.

MD Comput. 1998 Jan-Feb;15(1):31-9.

PMID:
9458661
38.

The telephone assessment program: efficient patient monitoring and clinician feedback.

Greist JH, Jefferson JW, Wenzel KW, Kobak KA, Bailey TM, Katzelnick DJ, Hagerson SJ, Dottl SL.

MD Comput. 1997 Sep-Oct;14(5):382-7. No abstract available.

PMID:
9308348
39.

A computer-administered telephone interview to identify mental disorders.

Kobak KA, Taylor LH, Dottl SL, Greist JH, Jefferson JW, Burroughs D, Mantle JM, Katzelnick DJ, Norton R, Henk HJ, Serlin RC.

JAMA. 1997 Sep 17;278(11):905-10.

PMID:
9302242
40.

Computerized screening for psychiatric disorders in an outpatient community mental health clinic.

Kobak KA, Taylor LH, Dottl SL, Greist JH, Jefferson JW, Burroughs D, Katzelnick DJ, Mandell M.

Psychiatr Serv. 1997 Aug;48(8):1048-57.

PMID:
9255838
41.

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study.

Lott M, Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Katz RJ, Schaettle SC.

J Clin Psychopharmacol. 1997 Aug;17(4):255-60.

PMID:
9241003
42.

Depression, use of medical services and cost-offset effects.

Simon GE, Katzelnick DJ.

J Psychosom Res. 1997 Apr;42(4):333-44. Review.

PMID:
9160273
43.

Effect of primary care treatment of depression on service use by patients with high medical expenditures.

Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Henk HJ.

Psychiatr Serv. 1997 Jan;48(1):59-64.

PMID:
9117501
44.

Computer-administered clinical rating scales. A review.

Kobak KA, Greist JH, Jefferson JW, Katzelnick DJ.

Psychopharmacology (Berl). 1996 Oct;127(4):291-301. Review.

PMID:
8923563
45.

Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization.

Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW.

Arch Gen Psychiatry. 1996 Oct;53(10):899-904.

PMID:
8857866
46.

Sertraline for social phobia: a double-blind, placebo-controlled crossover study.

Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC.

Am J Psychiatry. 1995 Sep;152(9):1368-71.

PMID:
7653696
47.

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC.

Arch Gen Psychiatry. 1995 Jan;52(1):53-60.

PMID:
7811162
48.

Teaching psychiatric residents to teach.

Katzelnick DJ, Gonzales JJ, Conley MC, Shuster JL, Borus JF.

Acad Psychiatry. 1991 Sep;15(3):153-9. doi: 10.1007/BF03341939.

PMID:
24449114
49.

Reversibility of psychiatric symptoms in a chronic solvent abuser: a case report.

Katzelnick DJ, Davar G, Scanlon JP.

J Neuropsychiatry Clin Neurosci. 1991 Summer;3(3):319-21.

PMID:
1821248

Supplemental Content

Loading ...
Support Center